Commit to needs-driven research and guarantee access to medicines
Our universities need to commit to global needs-driven research and development (R&D) for new medicines, vaccines, and diagnostics. Further, our universities should enact active policies that guarantee affordable access to the end-products of university research.
To do this, universities should:
- Make sure drugs that come from their research are affordable, and not overpriced.
Adopt Equitable Access Licensing policies for all medicines, vaccines and diagnostics produced from university research.
- Separate research from commercial interests.
Engage with innovative R&D frameworks, embracing the principle of separating (“de-linking”) the cost of R&D from the price of the resulting treatment.
Achieve a goal of receiving 20% of all research funding from non-traditional push & pull mechanisms by 2020, using internal incentives, participation in larger delinkage schemes and strategic non-profit partnerships.
- Call for government to address imbalances in research funding, and support important but underfunded areas of research.
Demand needs-driven funding mechanisms from government and philanthropic sources to reflect the global burden of diseases, including increasing spending on neglected diseases to 0.01% of GDP.
- Our universities
Our universities need to commit to needs-driven research and guarantee global access to resulting medicines.
Today: Universities Allied for Essential Medicines is counting on you
Universities Allied for Essential Medicines needs your help with “Commit to needs-driven research and guarantee access to medicines”. Join Universities Allied for Essential Medicines and 2,060 supporters today.